(Q40528700)

21 September 2017

title

Microrough implant surface topographies increase osteogenesis by reducing osteoclast formation and activity (English)

1 reference

21 September 2017

Lossdörfer S

1

1 reference

21 September 2017

Schwartz Z

2

1 reference

21 September 2017

Wang L

3

1 reference

21 September 2017

Lohmann CH

4

1 reference

21 September 2017

Turner JD

5

1 reference

21 September 2017

Wieland M

6

1 reference

21 September 2017

Cochran DL

7

1 reference

21 September 2017

Boyan BD

8

1 reference

21 September 2017

publication date

1 September 2004

1 reference

Journal of Biomedical Materials Research Part A

21 September 2017

published in

1 reference

21 September 2017

volume

70

1 reference

21 September 2017

issue

3

1 reference

21 September 2017

page(s)

361-369

1 reference

Response of normal female human osteoblasts (NHOst) to 17beta-estradiol is modulated by implant surface morphology.

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.30025

Osteoblast-mediated mineral deposition in culture is dependent on surface microtopography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.30025

Titanium surface roughness alters responsiveness of MG63 osteoblast-like cells to 1 alpha,25-(OH)2D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.30025

Both cyclooxygenase-1 and cyclooxygenase-2 mediate osteoblast response to titanium surface roughness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.30025

Local factor production by MG63 osteoblast-like cells in response to surface roughness and 1,25-(OH)2D3 is mediated via protein kinase C- and protein kinase A-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.30025

Inhibition of cyclooxygenase by indomethacin modulates osteoblast response to titanium surface roughness in a time-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.30025

Differential regulation of prostaglandin E2 synthesis and phospholipase A2 activity by 1,25-(OH)2D3 in three osteoblast-like cell lines (MC-3T3-E1, ROS 17/2.8, and MG-63)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.30025

Cytokine release by osteoblast-like cells cultured on implant discs of varying alloy compositions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.30025

Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.30025

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.30025

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.30025

RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.30025

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.30025

The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.30025

Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.30025

Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.30025

Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.30025

Evidence for distinct membrane receptors for 1 alpha,25-(OH)(2)D(3) and 24R,25-(OH)(2)D(3) in osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.30025

RGD-containing peptide GCRGYGRGDSPG reduces enhancement of osteoblast differentiation by poly(L-lysine)-graft-poly(ethylene glycol)-coated titanium surfaces.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.30025

Bone cement extracts modulate the osteoprotegerin/osteoprotegerin-ligand expression in MG63 osteoblast-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.30025

Transgenic mice overexpressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.30025

Regulation of osteoprotegerin mRNA levels by prostaglandin E2 in human bone marrow stroma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.30025

TGFbeta1 regulates 25-hydroxyvitamin D3 1alpha- and 24-hydroxylase activity in cultured growth plate chondrocytes in a maturation-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.30025

Expression of functional RANK on mature rat and human osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.A.30025

21 January 2018

Identifiers

DOI

10.1002/JBM.A.30025

0 references

1 reference